期刊文献+

内镜下经眶内壁眶减压术治疗甲状腺相关性眼病 被引量:2

Endoscopic transethmoid orbital medial wall decompression for thyroid associated ophthalmopathy
原文传递
导出
摘要 目的评价鼻内镜下经筛窦及眶内壁减压联合眶脂肪减压治疗甲状腺相关性眼病(TAO)的效果。方法回顾性分析TAO11例(17眼)的临床资料。患者均为眼球突出非组织活动期,内镜下行经筛窦及眶内壁眶减压联合脂肪减压手术,术后定期随访。结果术后6个月,眼球突出矫正度达(5.24±1.79)mm,与术前比较差异有统计学意义(P〈0.05),且术后双眼眼球突出度相差均〈2mm;术前角膜上皮异常者14眼(82.35%),术后减少为2眼(11.76%),差异有统计学意义(P〈0.05);术后睑裂高度平均下降(2.59±0.48)mm,与术前比较差异有统计学意义(P〈0.05)。术后无视力下降或眶内出血等并发症发生。结论鼻内镜下眶内壁减压联合眶脂肪减压术治疗甲状腺相关性眼病效果良好。 Objective To evaluate the efficacy of endoscopic transethmoid and orbital medial wall decompression combined with orbital fat decompression for thyroid associated ophthalmopathy (TAO). Methods The data of 17 eyes of 11 patients with TAO were selected and retrospectively analyzed. They reeeieved endoscopic transethmoid and orbital medial wall decompression combined with orbital fat decompression. All patients were followed up periodically. Results Six months after surgery, the mean reduction in proptosis was ( 5.24 +- 1.79 ) ram, the difference was statistically significant between before and after surgery ( P 〈 0.05 ). Postoperatively the difference of exophthalmos between the both eyes was within 2 mm. Corneal epithelial abnormalities decreesed from 14 eyes (82. 35% ) preoperative to 2 eyes (11.76%) postperative , the difference was statistically significant (P 〈 0. 05 ). And postoperative mean height of palpebral fissure decreased ( 2.59 ± 0.48 ) mm, the difference was statistically significant ( P 〈 0.05). There was no loss of visual acuity, orbital bleeding or other complication. Conclusion The endoscopic transethmoid orbital medial wall decompression combined with orbital fat decompression is an effective treatment for TAO.
出处 《中华眼外伤职业眼病杂志》 2017年第11期840-842,共3页 Chinese Journal of Ocular Trauma and Occupational Eye Disease
关键词 眼病 甲状腺相关性 眶减压术 经筛窦 内窥镜下 Ophthalmopathy, thyroid associated Orbital decompression, transethmoid medical wall, endoscopic
  • 引文网络
  • 相关文献

参考文献1

二级参考文献30

  • 1Trobe JD, Glaser JS, Laflamme P. Dysthyroid optic neuropathy : clinical profile and rationale for management. Arch Ophthalmol, 1978, 96: 1199-1209.
  • 2Chang EL, Bernardino CR, Rubin PA. Transcaruncular orbital decompression for management of compressive optic neuropathy in thyroid-related orbitopathy. Plast Reconstr Surg, 2003, 112 : 739 -747.
  • 3Choe CH, Cho RI, Elner VM. Comparison of lateral and medial orbital decompression for the treatment of compressive optic neuropathy in thyroid eye disease. Ophthal Plast Reconstr Surg, 2011, 27: 4-11.
  • 4Leong SC, White PS. Outcomes following surgical decompression for dysthyroid orbitopathy (Graves' disease ). Curr Opin Otolaryngol Head Neck Surg, 2010:18:37-43.
  • 5Schaefer SD, Soliemanzadeh P, Della' Rocca DA, et al. Endoscopic and transconjunctival orbital decompression for thyroid- related orbital apex compression. Laryngoscope, 2003, 113: 508-513.
  • 6Hatton MP, Rubin PA. Controversies in thyroid-related orbitopathy: radiation and decompression. Int Ophthalmol Clin, 2005, 45 : 1-14.
  • 7Liao SL, Chang TC, Lin LL. Transcaruncular orbital decompression: an alternate procedure for Graves ophthalmopathy with compressive optic neuropathy. Am J Ophthalmol, 2006, 141 : 810-818.
  • 8Shorr N, Baylis HI, Goldberg RA, et al. Transcaruncular approach to the medial orbit and orbital apex. Ophthalmol, 2000, 107 : 1459-1463.
  • 9Perry JD, Kadakia A, Foster JA. Transcaruncular orbital decompression for dysthyroid optic neuropathy. Ophthal Plast Reconstr Surg, 2003, 19 : 353-358.
  • 10Levy J, Puterman M, Lifshitz T, et al. Endoscopic Orbital Decompression for Graves' Ophthalmopathy. Isr Med Assoc J, 2004, 6: 673-676.

共引文献3

同被引文献8

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部